Here are four notes:
1. The new amniotic stem cell product is derived from human placental tissue.
2. Royal Biologics offers the product in liquid amnion and dehydrated dual layer patches.
3. Amnio-Maxx has been proven to enhance wound healing outcomes, decrease inflammation, fibrosis and scarring at the surgical site as well as reduce pain.
4. Providers have used amnion in spine surgeries, neurological surgeries, bariatric surgeries, sports medicine, wound care and trauma.
More articles on biologics:
Orthocell’s CelGro collagen rope may be superior option for ACL reconstruction: 4 key insights
CartiHeal secures $2.5M from Bioventus, financing reaches $21M — 3 key insights
Dr. Thomas Vogl performs 1st cases of Triojection in Germany: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
